lenalidomide has been researched along with tanshinone in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 1,445 | 10 | 1,033 |
| Protein | Taxonomy | lenalidomide (IC50) | tanshinone (IC50) |
|---|---|---|---|
| Polycomb protein EED | Homo sapiens (human) | 8.9 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 4.75 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.21 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 1.97 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.57 | |
| Polycomb protein SUZ12 | Homo sapiens (human) | 8.9 | |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 8.9 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 8.51 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 8.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, N; Kumar, R; Sharma, A | 1 |
1 other study(ies) available for lenalidomide and tanshinone
| Article | Year |
|---|---|
Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules.
Topics: Abietanes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Lenalidomide; Multiple Myeloma; Shelterin Complex; Telomerase; Telomere; Telomere-Binding Proteins | 2018 |